Faeth Therapeutics to participate in September investor conferences
Faeth Therapeutics (FTH) says management will participate in upcoming September investor conferences, with live webcasts available for Cantor and Morgan Stanley events.
Faeth Therapeutics (Nasdaq: FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced that management will participate in the following upcoming investor conferences:Live webcasts of the Cantor and Morgan Stanley…